US equities
|
TSLA
$360.46
▼-0.55%
MU
$895.21
▼-3.87%
NVDA
$216.77
▼-0.21%
AAPL
$346.51
▲+1.32%
SPCX
$145.83
▼-1.88%
SNDK
$1,334.56
▼-4.32%
META
$720.73
▼-2.17%
MSFT
$532.35
▼-1.31%
TSLA
$360.46
▼-0.55%
MU
$895.21
▼-3.87%
NVDA
$216.77
▼-0.21%
AAPL
$346.51
▲+1.32%
SPCX
$145.83
▼-1.88%
SNDK
$1,334.56
▼-4.32%
META
$720.73
▼-2.17%
MSFT
$532.35
▼-1.31%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
TenX Keane Acquisition - Ordinary Share
(NQ:
TENK
)
40.50
UNCHANGED
Last Price
Updated: 3:59 PM EDT, Aug 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about TenX Keane Acquisition - Ordinary Share
Bucking the Trend: 3 Stocks That Zoomed While the Market Crashed
↗
August 14, 2024
Even as the market crashed last week there were some outperforming stocks that went on to double- and triple-digit gains.
Via
InvestorPlace
Citius Pharmaceuticals To Receive 65 Million Shares Of TenX Keane For Merger Of Citius Oncology
August 06, 2024
Citius Pharmaceuticals To Receive 65 Million Shares Of TenX Keane For Merger Of Citius Oncology
Via
News Direct
Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
↗
August 06, 2024
Via
Benzinga
S&P 500 Down Over 100 Points; Actinium Pharmaceuticals Shares Plunge
↗
August 05, 2024
Via
Benzinga
Topics
Stocks
